NCT00542490 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Vaginal Cuff Brachytherapy: Clinical stage I-II endometrial cancer surgically staged. Stage I-II with any high-intermediate risk (H-IR) features OR Stage IIb any histology OR Stage I-II Papillary Serous or Clear Cell Histology Vaginal cuff brachytherapy Followed by Paclitaxel (175 mg/m2 over 3 hours) and carboplatin (AUC 6) Chemotherapy X 3 (high risk)
- id
- FG000
- title
- Vaginal Cuff Brachytherapy
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 23
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 21
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 2
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Vaginal Cuff Brachytherapy: Clinical stage I-II endometrial cancer surgically staged. Stage I-II with any high-intermediate risk (H-IR) features OR Stage IIb any histology OR Stage I-II Papillary Serous or Clear Cell Histology Vaginal cuff brachytherapy Followed by Paclitaxel (175 mg/m2 over 3 hours) and carboplatin (AUC 6) Chemotherapy X 3 (high risk)
- id
- FG000
- title
- Vaginal Cuff Brachytherapy
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 23
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 21
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 2
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle